Dr. Arun Chandavarkar

Biography

Core member of Biocon's leadership team Played a pivotal role in the evolution of Biocon over the last 26 years Ph.D. in Biochemical Engineering from the Massachusetts Institute of Technology (MIT), Cambridge, USA B.Tech. in Chemical Engineering from the Indian Institute of Technology, Mumbai  

Research Interest

Biocon's major areas of research now include cancer, diabetes, and other auto-immune diseases such as rheumatoid arthritis and psoriasis. Because of the high percentage of people in India who chew betel or tobacco, India accounts for eighty-six per cent of oral cancer in the world, known locally as "cancer cheek". Diabetes is prevalent, and people who do not wear shoes are at risk to have a minor scrape or injury develop into gangrene, or "diabetes foot".Biocon is also working on drugs to treat psoriasis, a skin pigment disease which can result in social ostracization.